Preferred Antibiotics for Community-Acquired Pneumonia in Pediatrics
Amoxicillin is the first-line antibiotic of choice for community-acquired pneumonia (CAP) in children, with a recommended dosage of 90 mg/kg/day divided into two doses (maximum 4 g/day). 1
First-Line Treatment by Age Group
Children Under 5 Years
- First-line: Amoxicillin 90 mg/kg/day divided into 2 doses for 5 days 1
- Alternative (for penicillin allergy): Cefpodoxime, cefuroxime, or cefprozil 1
Children 5 Years and Older
- First-line: Amoxicillin 90 mg/kg/day divided into 2 doses (maximum 4 g/day) for 5 days 1
- Alternative (for atypical pneumonia): Macrolides such as azithromycin 1, 2
Azithromycin Dosing for Atypical Pneumonia
For suspected Mycoplasma pneumonia or other atypical pathogens:
- Dosing: 10 mg/kg on day 1 (maximum 500 mg), followed by 5 mg/kg on days 2-5 (maximum 250 mg) 1, 2
- Alternative adult dosing: 500 mg as a single dose on Day 1, followed by 250 mg once daily on Days 2 through 5 2
Treatment Duration
Recent evidence suggests that shorter courses (5 days) may be as effective as longer courses (7-10 days) for uncomplicated pneumonia 1, 3. The American Academy of Pediatrics recommends:
- 5-day course for most uncomplicated CAP cases 1
- Treatment should be continued for at least 48-72 hours beyond symptom resolution 1
Hospitalization Considerations
Consider hospitalization for children with:
- Severe respiratory distress
- Oxygen saturation <92% or cyanosis
- Inability to maintain oral hydration
- Toxic appearance
- Failure to respond to outpatient management 1
For hospitalized children:
- Fully immunized: Ampicillin or penicillin G
- Not fully immunized or high local resistance: Ceftriaxone or cefotaxime 1
Monitoring Response
- Assess for clinical improvement within 48-72 hours of starting antibiotics 1
- Signs of improvement include decreased fever, improved respiratory rate, and decreased work of breathing
- If no improvement after 48-72 hours, reassess diagnosis and consider alternative antibiotics 1
Common Pitfalls to Avoid
- Underdosing amoxicillin: Using standard adult doses rather than weight-based dosing can lead to treatment failure 1
- Defaulting to macrolides as first-line therapy in young children with typical pneumonia 1
- Using unnecessarily broad-spectrum antibiotics when narrow-spectrum options are effective 1
- Defaulting to 10-day courses regardless of clinical response 1
- Not evaluating response after 48-72 hours of therapy 1
Antibiotic Stewardship Considerations
- Avoid unnecessary broad-spectrum antibiotics to prevent antimicrobial resistance 1
- Be aware of increasing macrolide resistance in Mycoplasma pneumoniae globally 1
- Adjust therapy based on clinical response rather than defaulting to fixed durations 1
The evidence strongly supports amoxicillin as the first-line treatment for pediatric CAP, with macrolides reserved for suspected atypical pathogens. High-dose amoxicillin (90 mg/kg/day) is recommended to overcome potential resistance, and a 5-day course is typically sufficient for uncomplicated cases.